We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




POC Glucose Testing

By HospiMedica staff writers
Posted on 14 Dec 2005
In an era of ever-increasing point-of-care (POC) testing, where less-accurate glucose meters are fast replacing laboratory testing, a new POC system promises more accuracy.

The HemoCue glucose 201 analyzer is a hand-held device that incorporates a small dedicated analyzer and disposable microcuvettes. More...
Employing patented technology and rigorous manufacturing standards, the system combines the precision and accuracy of a laboratory measurement with a speedy turn-around time and ease of use. Results are available within moments. The analyzer is the product of HemoCue AB (Angelholm, Sweden). The 201 analyzer is also available in a model that incorporates data-management capabilities. The analyzer can be used for screening, diagnosing, and monitoring diabetes.

According to the American Diabetes Association, glucose meters should produce test results that are within 5% of laboratory results, but no strip meters now meet that level of accuracy. An international standard is currently under development (ISO DIS 15197) that recommends accuracy of +/- 15 mg/dl for glucose values under 76 mg/dl and +/- 20% for higher glucose values.

The method of use is simple. The microcuvette is applied to a drop of blood--capillary, venous, or arterial--where it automatically draws the correct volume by capillary action. The microcuvette is inserted into the HemoCue instrument and the result is automatically displayed.




Related Links:
HemoCue

Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Syringe Pump
SP50 Series
Medical Adhesive
MED 5570U
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.